Table 2.
Univariate and multivariate Cox analysis of CD276 expression.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
Variables | Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P |
OS | ||||||
Gender (male) | 0.82 | 0.39-1.73 | 0.601 | |||
Age (≥65) | 1.37 | 0.52-3.57 | 0.522 | |||
Hormone secretion (yes) | 0.76 | 0.37-1.55 | 0.445 | |||
Laterality (right) | 0.91 | 0.45-1.86 | 0.796 | |||
Tumor size (≥7.5) | 0.76 | 0.38-1.52 | 0.431 | |||
T stage (T3+T4) | 1.14 | 0.52-2.48 | 0.741 | |||
N stage (N1) | 0.76 | 0.27-2.16 | 0.605 | |||
Stage (III+IV) | 1.06 | 0.5-2.25 | 0.88 | |||
R status (R1/2/X) | 1.22 | 0.6-2.47 | 0.589 | |||
Ki67 index (high) | 3.17 | 1.53-6.56 | 0.002 | 3.16 | 1.52-6.61 | 0.002 |
CD276 tumor cells (high) | 2.83 | 1.29-6.17 | 0.009 | 2.8 | 1.28-6.15 | 0.01 |
CD276 membrane (high) | 1.4 | 0.54-3.66 | 0.488 | |||
CD276 vascular (positive) | 1.26 | 0.63-2.53 | 0.517 | |||
DFS | ||||||
Gender (male) | 0.64 | 0.26-1.54 | 0.317 | |||
Age (≥65) | 0.55 | 0.13-2.36 | 0.424 | |||
Hormone secretion (yes) | 1.07 | 0.47-2.41 | 0.873 | |||
Laterality (right) | 1.6 | 0.71-3.6 | 0.253 | |||
Tumor size (≥7.5) | 0.8 | 0.36-1.81 | 0.596 | |||
T stage (T3+T4) | 1.62 | 0.69-3.81 | 0.272 | |||
N stage (N1) | 0.43 | 0.1-1.83 | 0.252 | |||
Stage (III+IV) | 1.2 | 0.51-2.83 | 0.678 | |||
R status (R1/2/X) | 3.27 | 1.44-7.39 | 0.005 | 2.8 | 1.23-6.39 | 0.014 |
Ki67 index (high) | 0.85 | 0.35-2.06 | 0.72 | |||
CD276 tumor cells (high) | 8.13 | 2.71-24.4 | <0.001 | 7.52 | 2.47-22.91 | <0.001 |
CD276 membrane (high) | 0.84 | 0.31-2.28 | 0.736 | |||
CD276 vascular (positive) | 1.15 | 0.52-2.56 | 0.733 |